114 related articles for article (PubMed ID: 14595690)
1. Proteomic analysis of the tumorigenic human prostate cell line M12 after microcell-mediated transfer of chromosome 19 demonstrates reduction of vimentin.
Liu X; Wu Y; Zehner ZE; Jackson-Cook C; Ware JL
Electrophoresis; 2003 Oct; 24(19-20):3445-53. PubMed ID: 14595690
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation.
Wei J; Xu G; Wu M; Zhang Y; Li Q; Liu P; Zhu T; Song A; Zhao L; Han Z; Chen G; Wang S; Meng L; Zhou J; Lu Y; Wang S; Ma D
Anticancer Res; 2008; 28(1A):327-34. PubMed ID: 18383865
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection.
Zhang X; Ladd A; Dragoescu E; Budd WT; Ware JL; Zehner ZE
Clin Exp Metastasis; 2009; 26(8):965-79. PubMed ID: 19771525
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vimentin or beta1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo.
Zhang X; Fournier MV; Ware JL; Bissell MJ; Yacoub A; Zehner ZE
Mol Cancer Ther; 2009 Mar; 8(3):499-508. PubMed ID: 19276168
[TBL] [Abstract][Full Text] [Related]
5. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.
Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL
Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238
[TBL] [Abstract][Full Text] [Related]
6. [Effects of vimentin on invasion and metastasis of prostate cancer cell lines PC-3M-1E8 and PC-3M-2B4].
Wei JC; Wu MF; Zhang YT; Zhao LP; Lu YP; Ma D
Ai Zheng; 2008 Jan; 27(1):30-4. PubMed ID: 18184460
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19.
Astbury C; Jackson-Cook CK; Culp SH; Paisley TE; Ware JL
Genes Chromosomes Cancer; 2001 Jun; 31(2):143-55. PubMed ID: 11319802
[TBL] [Abstract][Full Text] [Related]
8. Variable metastatic potentials correlate with differential plectin and vimentin expression in syngeneic androgen independent prostate cancer cells.
Burch TC; Watson MT; Nyalwidhe JO
PLoS One; 2013; 8(5):e65005. PubMed ID: 23717685
[TBL] [Abstract][Full Text] [Related]
9. Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferons.
Nagano K; Masters JR; Akpan A; Yang A; Corless S; Wood C; Hastie C; Zvelebil M; Cramer R; Naaby-Hansen S
Oncogene; 2004 Mar; 23(9):1693-703. PubMed ID: 14647428
[TBL] [Abstract][Full Text] [Related]
10. Vimentin significantly promoted gallbladder carcinoma metastasis.
Dong P; He XW; Gu J; Wu WG; Li ML; Yang JH; Zhang L; Ding QC; Lu JH; Mu JS; Chen L; Li SG; Ding LF; Wang JW; Liu YB
Chin Med J (Engl); 2011 Dec; 124(24):4236-44. PubMed ID: 22340393
[TBL] [Abstract][Full Text] [Related]
11. Proteomic studies coupled with RNAi methodologies can shed further light on the downstream effects of telomerase in glioma.
Thakkar D; Shervington L; Shervington A
Cancer Invest; 2011 Feb; 29(2):113-22. PubMed ID: 21261472
[TBL] [Abstract][Full Text] [Related]
12. The proteomic analysis of cisplatin resistance in breast cancer cells.
Smith L; Welham KJ; Watson MB; Drew PJ; Lind MJ; Cawkwell L
Oncol Res; 2007; 16(11):497-506. PubMed ID: 18306929
[TBL] [Abstract][Full Text] [Related]
13. Proteomics in the analysis of prostate cancer.
Naaby-Hansen S; Nagano K; Gaffney P; Masters JR; Cramer R
Methods Mol Med; 2003; 81():277-97. PubMed ID: 12725127
[No Abstract] [Full Text] [Related]
14. Chromosome 18 suppresses tumorigenic properties of human prostate cancer cells.
Gagnon A; Ripeau JS; Zvieriev V; Chevrette M
Genes Chromosomes Cancer; 2006 Mar; 45(3):220-30. PubMed ID: 16281261
[TBL] [Abstract][Full Text] [Related]
15. [Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones].
Yan XD; Pan LY
Zhonghua Fu Chan Ke Za Zhi; 2006 Sep; 41(9):584-7. PubMed ID: 17181965
[TBL] [Abstract][Full Text] [Related]
16. [Nuclear matrix proteins differentially expressed in human prostate cancer cell lines and benign prostatic hyperplasia epithelial cell line].
Sun TC; Xin L; Song LM; Zhou Y; Ning LF; Han LY; Guo Y; Yu HM; Wang HP
Zhonghua Nan Ke Xue; 2012 Jul; 18(7):583-9. PubMed ID: 22994041
[TBL] [Abstract][Full Text] [Related]
17. Effects of naturally occurring and synthetic organoselenium compounds on protein profiling in androgen responsive and androgen independent human prostate cancer cells.
Sinha R; Pinto JT; Facompre N; Kilheffer J; Baatz JE; El-Bayoumy K
Nutr Cancer; 2008; 60(2):267-75. PubMed ID: 18444160
[TBL] [Abstract][Full Text] [Related]
18. What can proteomic analyses contribute to understanding the molecular biology and clinical behavior of prostate cancer?
Ware JL
Expert Rev Proteomics; 2004 Dec; 1(4):485-92. PubMed ID: 15966843
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of a highly metastatic gastric cancer cell line using two-dimensional differential gel electrophoresis.
Takikawa M; Akiyama Y; Maruyama K; Suzuki A; Liu F; Tai S; Ohshita C; Kawaguchi Y; Bandou E; Yonemura Y; Yamaguchi K
Oncol Rep; 2006 Oct; 16(4):705-11. PubMed ID: 16969483
[TBL] [Abstract][Full Text] [Related]
20. Proteome profiling of human epithelial ovarian cancer cell line TOV-112D.
Gagné JP; Gagné P; Hunter JM; Bonicalzi ME; Lemay JF; Kelly I; Le Page C; Provencher D; Mes-Masson AM; Droit A; Bourgais D; Poirier GG
Mol Cell Biochem; 2005 Jul; 275(1-2):25-55. PubMed ID: 16335783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
